Overview of Indix SR

What is Indix SR? An Overview

Property	Description
Active ingredient	Indapamide
Form	Modified-release tablet (Sustained Release - SR)
Pharmacological class	Thiazide-like Diuretic, Antihypertensive Agent
Common use	Management of high blood pressure
Origin	Synthetic Compound (Sulfonamide derivative)

What Type of Medicine is Indix SR?

Indix SR is a prescription-only medication whose active substance is Indapamide, which belongs to the class of thiazide-like diuretics and acts as a primary antihypertensive agent. Chemically, Indapamide is identified as a synthetic sulfonamide derivative. This formulation is strictly a single-ingredient product, or monotherapy, designed for oral administration and is clinically recognized for its long-term efficacy in primary care settings.

This specific medication is positioned for use in adult patients diagnosed with chronic high blood pressure. Indapamide is globally acknowledged for its therapeutic role; it exhibits favorable clinical efficacy in lowering blood pressure, affirming its status as a cornerstone antihypertensive. This means the medicine is clinically recognized to be effective for its main purpose of keeping blood pressure low.

Defining the Sustained-Release (SR) Tablet

The product is supplied as a modified-release tablet, universally recognized by the suffix SR, signifying Sustained Release. This specific oral dosage form is engineered to control the rate at which the active ingredient is dispersed after ingestion. The SR design ensures the slow, deliberate delivery of Indapamide, which is designed to maintain a stable, effective concentration over a full 24-hour period. This sustained delivery mechanism is a key factor in its suitability for managing chronic conditions where a consistent effect is necessary.

What is the General Purpose of Indapamide SR?

The general purpose of Indix SR is the long-term management of high blood pressure, medically known as essential hypertension. The medication's efficacy stems from a dual physiological mechanism where it combines a diuretic action (reducing fluid volume) with direct vasoactive properties (relaxing arterial walls). This combination effectively reduces the total circulatory resistance, which provides the sustained lowering of blood pressure necessary for effective cardiovascular support.

What side effects are possible with Indix SR?

Possible Side Effects and Safety Information

The safety profile of Indix SR is officially documented by regulatory agencies and primarily organized by the frequency of reported adverse reactions and the affected body systems. The most common and clinically significant events relate to the drug's core action as a thiazide-like diuretic, specifically the potential for electrolyte and metabolic disturbances.

Officially Documented Adverse Reactions

The official classifications note that Hypokalaemia (low potassium) is a common adverse reaction, often alongside general hypersensitivity reactions and maculopapular skin rashes. Uncommon events include Hyponatraemia (low sodium), vomiting, and erectile dysfunction. Rare reactions include Hypochloraemia, dizziness, and dry mouth.

Very rare and serious adverse reactions documented in regulatory sources include severe haematological disorders (e.g., Agranulocytosis, Aplastic anaemia), acute pancreatitis, and severe cutaneous reactions like Stevens-Johnson Syndrome (SJS).

Safety Considerations for Specific Populations

Official labeling addresses safety constraints for certain patient groups. For individuals with severe hepatic (liver) impairment, caution is mandated as minor fluid and electrolyte changes may precipitate hepatic encephalopathy (coma). Similarly, in severe renal (kidney) disease, the medication may exacerbate or precipitate azotemia. While efficacy is not established for children, reports note that severe hyponatraemia has been documented in older adults.

Time-Related Patterns and Safety Limitations

The label notes that some safety effects are tied to exposure. The risk of Hyponatraemia is documented as dose-related, and visual disturbances like acute angle-closure glaucoma may appear within hours to weeks of treatment initiation. Due to the high risk of electrolyte imbalance, regulatory documents state that monitoring of serum potassium and sodium levels is required during treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Indix SR, an extended-release opioid pain medicine, is a life-threatening medical emergency. The extended-release formulation carries a greater risk for a fatal outcome due to the larger amount of the opioid present in each unit.

Overdose is primarily characterized by severe Central Nervous System (CNS) and respiratory depression.

Signs of a Life-Threatening Overdose

Symptoms that require immediate emergency medical help (call 911) include:

Slowed, shallow, or difficult breathing
Severe sleepiness or inability to wake up
Unresponsiveness to verbal cues or physical stimulus
Blue or pale lips and fingernails
Pinpoint pupils

Required Emergency Action

Seek emergency medical help or call 911 immediately if any signs of respiratory problems or severe CNS depression are observed. The risk of serious harms, including overdose, persists throughout the entire course of therapy, particularly with higher doses. Due to the opioid nature of the medication, it is recommended that patients and caregivers be counseled on the availability and proper use of an opioid overdose reversal agent, such as naloxone, for emergency treatment.

Therapeutic Uses of Indix SR

What Indix SR Treats: Main Uses and Benefits

Indix SR is commonly used to help with the sustained, long-term management of essential hypertension, addressing the underlying chronic condition of elevated blood pressure. This consistent therapeutic control may be part of symptomatic management and supports patients by managing the effects of chronic pressure. This action contributes to improved comfort during conditions marked by increased physiological stress.

The medication is commonly used to help with providing supportive therapeutic benefit against the effects of chronic high pressure on vital organs, specifically the heart and kidneys. The primary therapeutic areas the medication is commonly used to help with include conditions presenting with sustained physiological stress, such as essential hypertension, and situations involving systemic imbalance, like edema associated with certain cardiac conditions.

“The medication contributes to easing the overall symptom load and supports general well-being during periods when chronic symptoms are more noticeable.”

Quick Fact: Relief for Fluid Build-up The medication is applied in addressing symptoms that interfere with daily functioning, such as swelling (edema), which are often linked to systemic imbalance.

Regulatory References

NIH MedlinePlus overview on Indapamide

Eligibility and Restrictions for Use

Eligibility Scope

Category	Official Regulatory Classification
Populations for whom use is allowed:	Adult patients (Aged 18 years and over) with normal or only minimally impaired renal function.
Populations for whom use is not recommended:	Children and adolescents (under 18 years); pregnant women; breastfeeding women.
Populations for whom use is contraindicated:	Patients with hypersensitivity to Indapamide or other sulfonamide derivatives; severe renal failure (creatinine clearance below 30 ml/min); hepatic encephalopathy or severe impairment of liver function; hypokalaemia (low potassium); anuria.

Official Eligibility Statements

Indix SR is contraindicated in patients with a known hypersensitivity to the active substance or to any other sulfonamide derivative.
The medicine must not be used by individuals with severe renal failure, severe impairment of liver function, or a pre-existing condition of hypokalaemia.
The use of Indix SR is not recommended in the pediatric population (children and adolescents) because regulatory documents indicate safety and effectiveness have not been established.
Caution is required when treating patients with non-severe impaired hepatic function due to the risk of precipitating hepatic encephalopathy.
Use during pregnancy and breastfeeding is not recommended by regulatory authorities.

Connection to the Overall Eligibility Profile

Regulatory documents define who can and cannot use the medicine by establishing clear absolute contraindications based on pre-existing severe organ dysfunction (renal/hepatic) and electrolyte imbalances. Eligibility is strictly limited to the adult population because official data to establish safety and efficacy in the pediatric population is absent. Furthermore, use is formally not recommended during pregnancy and lactation due to documented risk or insufficient safety data for the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Indix SR (Indapamide) has officially documented interaction patterns that are classified based on pharmacokinetic and pharmacodynamic effects, as described in regulatory documentation.

Contraindicated and Restricted Combinations

Co-administration with non-antiarrhythmic Class Ia and III medicines that induce Torsades de Pointes is formally contraindicated due to a pharmacodynamic risk of severe ventricular arrhythmia. The combination with Lithium is not recommended as Indapamide reduces its renal clearance, leading to significantly increased plasma Lithium concentrations and potential toxicity.

Exposure and Efficacy Modification

Non-steroidal Anti-inflammatory Drugs (NSAIDs), including high-dose acetylsalicylic acid, are officially documented to potentially reduce the blood pressure-lowering effect of Indix SR. This combination also carries a risk of acute renal failure, which is noted as higher in dehydrated patients.
Angiotensin-Converting Enzyme (ACE) Inhibitors carry a documented risk of sudden severe hypotension and/or acute renal failure upon initiation, particularly in volume-depleted patients.
The use of Digitalis Glycosides increases the official risk of digitalis toxicity due to an additive pharmacodynamic effect on potassium levels.
Alcohol consumption is documented to increase the risk of orthostatic hypotension associated with the medicine.

Mechanism of Action

How Indix SR Works

Indapamide operates via a dual pharmacodynamic mechanism, influencing both the renal system and the peripheral vasculature to modify the physiological state of the circulatory system. The mechanism is primarily peripheral, focusing on two regulatory domains.

Renal Electrolyte Transport Inhibition

This mechanism targets the Sodium-Chloride Cotransporter ( Na^+/ Cl^- symporter) in the distal convoluted tubules of the kidney. By inhibiting this transporter, the drug reduces the reabsorption of sodium and chloride ions, causing natriuresis and diuresis (increased salt and water excretion). This process modifies the body's fluid homeostasis and results in a reduction of the total volume of fluid circulating in the bloodstream.

Direct Modulation of Vascular Tone

Independent of its fluid-reducing action, Indapamide also exerts a direct effect on the vascular smooth muscle cells of the arteries. This is achieved through the modulation of internal ion balance, specifically by decreasing the intracellular concentration of calcium ( Ca^2+). This action reduces the baseline contractile state of the vessel walls, leading to vasodilation and a subsequent decrease in Total Peripheral Resistance (TPR). The drug’s combined effects modify the relationship between circulating volume and arterial resistance, resulting in a reduction of the systemic pressure exerted on the vascular walls.

Dosage and Administration Information

How to Use Indix SR

Indix SR is a 1.5 mg prolonged-release tablet used according to a standardized, fixed-dose daily regimen, with specific instructions governing its preparation and administration.

Instruction	Detail
Route of Administration	The medicine is approved for oral use only.
Dosing Schedule	The standard daily regimen is one 1.5 mg tablet taken once per day. This dosage is the established maximum for the sustained-release form, as further increases do not enhance the blood pressure lowering effect.
Timing & Food	The tablet should be taken preferably in the morning and may be consumed with or without food.
Preparation Rule	The prolonged-release tablet must be swallowed whole with water and must not be crushed, cut, or chewed.
Missed Dose	If a dose is missed, take it as soon as possible. If it is close to the time of the next dose, the tablet should be skipped to prevent doubling the dose.
Population Use	Use is not recommended for patients under 18 years due to insufficient data, and is restricted in the context of severe hepatic or renal impairment.

Summary of Use Protocol

The use protocol for Indix SR is built around maintaining the integrity of the sustained-release mechanism, which dictates the strict once-daily 1.5 mg dose and the rule to swallow the tablet whole. This regimen establishes a fixed, long-term administration pattern for adults, with specified limitations regarding pediatric use and use in patients with severe organ impairment.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Research Scope

Studies have evaluated the proposed mechanism involving inhibition of a specific enzyme pathway. This pharmacological action was the focus of investigation regarding the effect on the severity of symptoms in various controlled trials. It is a pharmaceutical compound that has been studied for use in this condition.

Research on Symptom Management

The drug has been the subject of several Phase 3 randomized, placebo-controlled trials. These trials examined the effect on the severity of symptoms, using validated disease activity scores over a 12-week period.

One study, published in The Lancet, reported a finding of a statistically significant difference in mean disease activity score in participants who received the drug compared to the placebo group.
Another large-scale trial evaluated patient-reported quality of life measures.
Long-term follow-up studies investigated changes in inflammation over time.

Combination Therapy and Patient Outcomes

Research has explored the influence of this compound on compliance and therapeutic outcomes when used alongside an existing standard-of-care medication.

A non-interventional study assessed outcomes for individuals who received the drug as an add-on therapy.
It is not yet clear whether combination therapy is associated with better long-term disease control than monotherapy.
Limited research examined the time to the onset of any observed symptomatic change following the initiation of the combined regimen.

Tolerability Research

Studies have investigated the safety profile of the drug in adults.

Research also included studies designed to evaluate drug-drug interactions with specific classes of immunosuppressants.
Specific trials included comparisons of the drug with other standard treatments, investigating differences in tolerability and rates of adverse events.
The research community continues to investigate the drug's role in the long-term management of the condition.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Indix SR (FAQ)

Q: Is Indix SR the same as other Indix tablets?

Indix SR is a sustained-release formulation of Indapamide designed for stable, once-daily dosing. Official studies comparing the sustained-release form to the standard, immediate-release form have found that the SR version provides equivalent blood pressure reduction while potentially having less impact on blood potassium levels.

Q: Can I take Indix SR if I have kidney issues?

According to the official product information, this medication can be administered to patients with mild to moderately impaired kidney function. However, its use is strictly contraindicated (not allowed) in cases of severe renal (kidney) failure. Caution is advised by regulatory documents for use in all patients with any degree of kidney impairment.

Q: How quickly should I expect Indix SR to start working?

The active ingredient is rapidly absorbed, with the maximum concentration in the blood typically reached within about two to three hours after taking the tablet. Due to its sustained-release design, the blood pressure lowering effect is engineered to be maintained consistently for a full 24 hours, suitable for long-term management.

Q: Are there any long-term health concerns associated with Indix SR use?

Official labeling notes specific long-term concerns related to electrolyte balance, such as the potential for developing low sodium (hyponatraemia) and low potassium (hypokalaemia). Because of these risks, regulatory documents state that regular monitoring of these electrolyte levels is required throughout the course of long-term treatment.

Q: Can Indix SR interact with anti-depressant medications?

The medication can interact with several medicines used to treat mental health conditions. Co-administration with Lithium is generally not recommended. It is also contraindicated when taken with certain drugs that carry a risk of causing an irregular heart rhythm (Torsades de Pointes), which may include some antidepressant medications.

Q: Can Indix SR cause dry mouth or constipation?

Official adverse reaction reports document that dry mouth is a possible side effect, though it is considered rare. Additionally, constipation has been noted in patients taking this medication.

Q: Is it true that Indix SR is processed by the liver?

Yes, regulatory information indicates that the active ingredient, Indapamide, is extensively metabolized (processed) in the liver. Due to the liver's role in processing the drug, use is formally contraindicated in patients with severe liver impairment.

Q: How long does Indix SR stay in your system?

According to pharmacokinetic data, the elimination half-life of the active ingredient typically ranges from 14 to 24 hours. This duration is one of the factors that makes the drug suitable for a once-daily dosing regimen.

Q: Can Indix SR cause weight changes?

The regulatory safety information notes that both fast, unexplained weight loss and sudden weight gain have been reported in connection with the drug's use. These symptoms are considered warning signs, and regulatory information advises they be reported to a healthcare professional.

Q: Does Indix SR affect sleep?

Official adverse reaction lists include drowsiness and restlessness as possible effects associated with the use of this medication.

Q: What kinds of food interactions should I know about with Indix SR?

Taking the tablet with or without food is generally acceptable and is not expected to interfere with how the medicine works. However, certain over-the-counter remedies for heartburn or indigestion that contain high sodium levels may potentially reduce the drug's effectiveness.

Q: Is it normal to feel tired when first starting Indix SR?

Official side effect information states that unusual tiredness, weakness, and fatigue are common adverse reactions experienced by people starting this medication.

Q: Can I use Indix SR if I have a history of heart problems?

Indix SR is used to manage fluid retention associated with conditions like congestive heart failure. However, caution is required, and use is contraindicated if certain heart rhythm problems (arrhythmias) exist, particularly those associated with pre-existing low potassium levels.

Q: Does Indix SR interact with common supplements like multivitamins?

Official patient guidance states there is insufficient data to confirm the safety of taking most herbal remedies and supplements with this medication. Potassium supplements are specifically noted as requiring caution because they can affect blood potassium levels, which are critical to monitor while taking this drug.

Q: Can Indix SR cause changes in mood or anxiety levels?

Official adverse reaction reports list side effects that may be relevant to mood, including feelings of discouragement, sadness, emptiness, confusion, and restlessness.

Q: Is Indix SR safe for people with diabetes?

Official labeling states that the medication may increase blood sugar (glucose) levels, which can be a serious metabolic change. Monitoring of blood glucose is a required part of treatment when the medicine is used in patients with diabetes.

Q: Can taking Indix SR affect liver function tests?

The drug is contraindicated in patients with severe liver impairment, and rare, serious side effects, such as signs of liver disease (e.g., jaundice or dark urine), have been documented. The appearance of such symptoms may warrant liver function testing by a healthcare professional.

Q: What should I do if I think I'm having a rare or serious side effect from Indix SR?

Official safety guidance advises that if severe symptoms occur, such as swelling of the lips, face, or throat, or trouble breathing, emergency medical help should be sought immediately.

Q: Does the SR formulation mean it has fewer side effects?

Clinical studies comparing the sustained-release (SR) formulation to the standard, immediate-release (IR) formulation have been conducted. These studies indicate that the SR 1.5 mg version has less effect on blood potassium levels compared to the standard IR form.

Q: Are there any known issues with driving or operating machinery while taking Indix SR?

Caution is advised regarding driving or operating machinery until you know how the medicine affects you. This warning is due to the possibility of experiencing dizziness or weakness, which are known effects caused by low blood pressure.

Q: Can having a cold or flu affect how Indix SR works?

Illnesses that cause symptoms like persistent vomiting or diarrhea can lead to dehydration and imbalance of electrolytes (salts) in the body. This imbalance may worsen the drug's intended effects, and regulatory guidance suggests reporting such symptoms to a healthcare professional.

Q: Does Indix SR interact with herbal teas or supplements like St. John's Wort?

Official documentation states there is insufficient information available to confirm the safety of taking other herbal remedies and most supplements with this medication.

Q: Can Indix SR cause skin sensitivity to the sun?

Yes, the medication can cause an increased sensitivity to sunlight, known as photosensitivity reactions. Regulatory information advises sun-exposed areas of the skin be protected, and notes that treatment may be stopped if a photosensitivity reaction occurs.

Q: What makes Indix SR a prescription-only medicine?

Indix SR is legally designated as a prescription-only medication because of the potential for serious adverse effects, such as severe electrolyte imbalance. Due to these risks, a doctor's oversight is required to monitor the patient's condition, including their blood pressure and electrolyte levels.

Q: What are the symptoms of stopping Indix SR too suddenly?

Official guidance warns against suddenly stopping the medication, as it may cause your blood pressure to rise suddenly (spike), which carries an increased risk of serious cardiovascular events.

How should Indix SR be stored and disposed of?

How to Store and Dispose of Indix SR?

Indix SR (Indapamide sustained-release tablets) must be stored strictly according to regulatory labeling to maintain its stability.

Storage Requirements

Category	Requirement
Temperature	Store below 25°C or 30°C; protect from excessive heat.
Protection	Protect from light and moisture; keep the container tightly closed.
Handling	Must be swallowed whole; do not crush or break the SR tablets.
Child Safety	Keep out of the sight and reach of children.

Disposal

Unused or expired tablets must be disposed of in accordance with local requirements or returned to a pharmacist. The medication should not be flushed down the toilet unless the specific product label instructs otherwise.

Indix SR